EXAS – exact sciences corporation (US:NASDAQ)
Stock Stats
News
Abivax Announces Former Prometheus COO, Mark Stenhouse, Appointed as Board Observer & Advisor to Abivax [Yahoo! Finance]
Exact Sciences Unveils Data Showing Promise of Multi-Cancer Early Detection at AACR Special Conference on Liquid Biopsy
Exact Sciences Co. (NASDAQ: EXAS) had its price target lowered by analysts at Piper Sandler from $85.00 to $75.00. They now have an "overweight" rating on the stock.
Exact Sciences Co. (NASDAQ: EXAS) had its price target raised by analysts at Jefferies Financial Group Inc. from $84.00 to $85.00. They now have a "buy" rating on the stock.
Exact Sciences Co. (NASDAQ: EXAS) had its price target lowered by analysts at Citigroup Inc. from $80.00 to $75.00. They now have a "buy" rating on the stock.
Form SC 13G EXACT SCIENCES CORP Filed by: Capital World Investors
Form 4 EXACT SCIENCES CORP For: Nov 13 Filed by: Conroy Kevin T
Form SC 13G/A EXACT SCIENCES CORP Filed by: WELLINGTON MANAGEMENT GROUP LLP
Form 10-Q EXACT SCIENCES CORP For: Sep 30
Form 8-K EXACT SCIENCES CORP For: Nov 05
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.